IDEXX Labs (IDXX) Misses Q1 EPS by 2c; Adjusts FY13 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $553.48 -0.8%
Revenue Growth %: +8.2%
Financial Fact:
Interest expense: -7.79M
Today's EPS Names:
CFFI, ZGN, SSNC, More
Revenue Growth %: +8.2%
Financial Fact:
Interest expense: -7.79M
Today's EPS Names:
CFFI, ZGN, SSNC, More
Join SI Premium – FREE
IDEXX Labs (NASDAQ: IDXX) reported Q1 EPS of $0.81, $0.02 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $0 versus the consensus estimate of $341.06 million.
IDEXX Labs sees FY2013 EPS of $3.43-3.46, versus prior guidance of $3.42-3.52 and the consensus of $3.54. IDEXX Labs sees FY2013 revenue of $1.38-1.39 billion, versus the consensus of $1.40 billion.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
IDEXX Labs sees FY2013 EPS of $3.43-3.46, versus prior guidance of $3.42-3.52 and the consensus of $3.54. IDEXX Labs sees FY2013 revenue of $1.38-1.39 billion, versus the consensus of $1.40 billion.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Sonoco (SON) Misses Q3 EPS by 13c
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
